SCHEMBL7325327

SCHEMBL7325327

N#Cc1cc(-c2ccccn2)nn1-c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
MCL1 Q07820 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
METAP1 P53582 2/20 0.46
F12 P00748 1/20 0.42
GRM5 P41594 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GPR35 Q9HC97 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326180 0.81 ALDH1A1 (0.54) MAPTKDM4EMAPK1ALDH1A1HPGD
SCHEMBL7233586 0.80 MAPT (0.53) MAPTKDM4EMAPK1ALDH1A1HPGD
SCHEMBL7242296 0.80 PTGS2 (0.47) MAPTKDM4EMAPK1ALDH1A1METAP1
SCHEMBL7312377 0.79 MAPT (0.40) MAPTKDM4EMAPK1ALDH1A1HPGD
SCHEMBL30795240 0.75 HTT (0.55) MAPTKDM4EALDH1A1METAP1F12
SCHEMBL3924704 0.75 HTT (0.55) MAPTKDM4EALDH1A1METAP1F12
SCHEMBL7319092 0.73 PTGS1 (0.60) MAPTPOLB
SCHEMBL3519438 0.69 ALDH1A1 (0.54) MAPTKDM4EMAPK1ALDH1A1TDP1
SCHEMBL12074966 0.69 KDM4E (0.45) KDM4EMAPK1ALOX15TDP1METAP1
SCHEMBL1674090 0.69 FLT3 (0.64) MAPTALDH1A1METAP1F12GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885KDM4E 2261/4885MAPK1 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.